Literature DB >> 21790269

The relevance of Caenorhabditis elegans genetics for understanding human psychiatric disease.

Xin Wang1, Gregory R Sliwoski, Edgar A Buttner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21790269     DOI： 10.3109/10673229.2011.599185

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN： 1067-3229            Impact factor:   3.732


× No keyword cloud information.
  3 in total

Review 1.  Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Authors:  Fernando Calahorro; Manuel Ruiz-Rubio
Journal:  Invert Neurosci       Date:  2011-11-08

2.  Methods for studying the mechanisms of action of antipsychotic drugs in Caenorhabditis elegans.

Authors:  Limin Hao; Edgar A Buttner
Journal:  J Vis Exp       Date:  2014-02-04       Impact factor: 1.355

3.  A genome-wide RNAi screen in Caenorhabditis elegans identifies the nicotinic acetylcholine receptor subunit ACR-7 as an antipsychotic drug target.

Authors:  Taixiang Saur; Sarah E DeMarco; Angelica Ortiz; Gregory R Sliwoski; Limin Hao; Xin Wang; Bruce M Cohen; Edgar A Buttner
Journal:  PLoS Genet       Date:  2013-02-28       Impact factor: 5.917
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.